Understanding how chronic liver disease patients with organ failure fare after non‑emergency hospital stays

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study conducted at ILBS in New Delhi. It tracks adults with chronic liver disease who are non‑electively hospitalized, documenting their clinical course, organ failures, therapies, and outcomes over six months. The goal is to identify differences in progression and prognosis related to liver failure with or without extra‑hepatic organ failure. Laboratory, clinical, inflammatory, and regenerative markers are collected to explore potential disease trajectories. No intervention is provided as part of the study; data are used to understand real-world outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age 18-70 years
2. CLD with or without cirrhosis with 1st or subsequent admissions for decompenasation and irrespective of any prior decompensation
3. Non-electively hospitalized

Exclusion Criteria:

1. HCC
2. NCPF/EHPVO
3. Pregnancy
4. Post-Liver transplant

Where it's running

• Institute of Liver & Biliary Sciences (ILBS)
  New Delhi, National Capital Territory of Delhi, India Recruiting

Study contacts

• Study coordinator: Dr Amanjot Kaur, MD
• Email: amanjotbahri@gmail.com
• Phone: 01146300000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Copper supplementation for people with cirrhosis

  This trial will try giving copper supplements to adults with cirrhosis who have low copper levels or signs of copper deficiency to see if liver-related health improves.

  Recruiting University of Washington · Seattle, Washington · NCT07471542

• Understanding social and health needs of people with chronic liver disease in outpatient care

  This project will see how common social needs are and whether adults with chronic liver disease want their outpatient providers to help with them.

  Recruiting Indiana University · Indianapolis, Indiana · NCT07191886

• Using rifaximin to improve liver transplant outcomes

  This study is testing if taking the antibiotic rifaximin before and after liver transplant surgery can help prevent early problems with the new liver in adults.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT06743464

• Endoscopic ultrasound shear wave elastography for measuring liver fibrosis

  This study will test whether endoscopic ultrasound shear wave elastography and attenuation imaging can estimate liver fibrosis compared with biopsy and FibroScan in adults with suspected MASLD or MASH.

  Recruiting at 3 sites Olympus Corporation of the Americas · Newport Beach, California and 2 other locations · NCT06592820

• Comparing intravenous and under-skin LAENNEC for alcoholic and non-alcoholic fatty liver disease

  This will test whether 10 ml intravenous LAENNEC given twice weekly for six weeks works better and is as safe as 4 ml subcutaneous LAENNEC in adults 19–70 with alcoholic or non‑alcoholic fatty liver disease.

  Recruiting Phase 3 Green Cross Wellbeing · Yongin-si · NCT06493799

• Gathering data on hepatomiR for liver disease outcomes

  This study is trying to see how a new test for liver disease can help doctors understand and predict serious problems in patients with chronic liver issues.

  Recruiting Karl Landsteiner University of Health Sciences · Sankt Pölten, Lower Austria · NCT06432582

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.